Olivier Elemento
| Olivier Elemento | |
|---|---|
Elemento in 2024 | |
| Born | |
| 🎓 Alma mater | University Paul Sabatier (BS) INSA Toulouse (MS) University of Paris (MS) University of Montpellier (PhD) |
| 💼 Occupation | |
| Known for | AI applications in oncology; leadership of the Englander Institute for Precision Medicine |
| 🏅 Awards | NSF CAREER Award (2012) Walter B. Wriston Research Scholar (2016–2019) Clarivate Highly Cited Researcher (2019, 2020, 2022, 2023, 2024) |
Olivier Elemento is a French‑American computational biologist who directs the Caryl and Israel Englander Institute for Precision Medicine (EIPM) at Weill Cornell Medicine in New York City. As of June 2025, he has authored more than 500 peer‑reviewed publications, and his work has been cited over 43,000 times, giving him an h‑index of 119.[1]
Early life and education
Elemento earned a bachelor’s degree in mechanical engineering from the University Paul Sabatier in Toulouse. He obtained master’s degrees from INSA Toulouse (mechanical engineering) and the University of Paris Dauphine (intelligent systems), then completed a doctorate in computational biology at the University of Montpellier/CNRS in 2003, under the joint supervision of Olivier Gascual and Marie-Paule Lefranc. He carried out post‑doctoral research at Princeton University’s Lewis‑Sigler Institute for Integrative Genomics, working in Saeed Tavazoie's laboratory.
Career
Elemento joined Weill Cornell Medicine in 2008 and became full professor of physiology and biophysics with tenure in 2019. In September 2017, he was appointed director of the Englander Institute for Precision Medicine, succeeding founding director Mark Rubin.[2]
In 2020, he led the launch of a multi‑institutional whole‑genome‑sequencing initiative with NewYork‑Presbyterian Hospital and Illumina, described by Genetic Engineering & Biotechnology News as “the largest clinical WGS effort of its kind in the United States.”[3] The New York Times Magazine later highlighted the project.[4]
In September 2022, he and Yaël Bensoussan became co‑principal investigators of 'Voice as a Biomarker of Health', an NIH Bridge2AI consortium building voice‑based diagnostics.[5] The Verge called the effort “an attempt to turn the human voice into a new vital sign.”[6]
Outside academia, he co‑founded Volastra Therapeutics, a clinical-stage biotech company, which raised US $60 million in Series A financing in 2023.[7]
Research and selected findings
Elemento’s laboratory integrates high‑throughput sequencing, single‑cell technologies and machine‑learning models.
- Artificial‑intelligence approaches in oncology. Among many achievements, Dr. Elemento and his group developed the machine‑learning model PrOCTOR, described as a “Moneyball” approach to predicting clinical‑trial toxicity.[8]. He delivered one of the opening‑plenary lectures “Towards AI‑driven cancer precision medicine” at AACR Annual Meeting (June 22, 2020).[9]
- AI embryo assessment. Dr. Elemento contributed to the development of STORK, a computer‑vision system (led by Iman Hajirasouliha) that outperformed embryologists at grading IVF embryos; profiled in Wired.[10]
- Spatial‑omics of cancer and infectious disease. Dr. Elemento led the development of UTAG, an algorithm for tissue‑architecture mapping.[11]. He co‑led a Nature study mapping COVID‑19 lung pathology.[12]
Leadership and advisory roles
- Scientific Review Council member, Pershing Square Sohn Cancer Research Alliance.[13]
- Board member, Advancium Health Network.[14]
- Scientific Advisory Board member, Owkin.[15]
- Scientific Advisory Board member, Harmonic Discovery.[16]
- Scientific Advisory Board member, Pannex Therapeutics.[17]
Media and policy commentary
- The ASCO Post ran a 2018 interview on his precision‑medicine work.[18]
- Authored a 2018 Wall Street Journal op‑ed on sequencing reimbursement.[19]
Awards and honours
- NSF CAREER Award (2012).[20]
- Walter B. Wriston Research Scholar, Weill Cornell Medicine (2016–2019).[21]
- Clarivate Highly Cited Researcher (2019, 2020, 2022, 2023, 2024).[22]
Selected publications
- Elemento O.; Khozin S.; Sternberg C.N. (2025). “The Use of Artificial Intelligence for Cancer Therapeutic Decision‑Making.” NEJM AI. doi:10.1056/AIra2401164.
- Bhinder B.; Gilvary C.; Madhukar N.S.; Elemento O. (2021). “Artificial Intelligence in Cancer Research and Precision Medicine.” Cancer Discovery 11: 900–915. doi:10.1158/2159‑8290.CD‑21‑0090.
- Rendeiro A.F.; Ravichandran H.; Bram Y.; Chandar V.; Kim J.; Meydan C.; Park J.; Foox J.; Hether T.; Warren S.; Kim Y.; Reeves J.; Salvatore S.; Mason C.E.; Swanson E.C.; Borczuk A.C.; Elemento O.; Schwartz R.E. (2021). “The spatial landscape of lung pathology during COVID‑19 progression.” Nature 593: 564–569. doi:10.1038/s41586‑021‑03475‑6.
- Gayvert K.; Madhukar N.S.; Elemento O. (2016). “A data‑driven approach to predicting successes and failures of clinical trials.” Cell Chemical Biology 23 (10): 1294–1301. doi:10.1016/j.chembiol.2016.07.023.
Personal life
Elemento was born and raised in France and holds dual French‑American citizenship.
See also
- Precision medicine
- Computational oncology
References
- ↑ "Olivier Elemento – Google Scholar". Google Scholar. Retrieved June 11, 2025.
- ↑ "Dr. Olivier Elemento appointed director of the Englander Institute for Precision Medicine". Weill Cornell Medicine. September 15, 2017. Retrieved June 11, 2025.
- ↑ "Large, Clinical, Sequencing Initiative Hopes to Uncover Genetic Disease Risk". Genetic Engineering & Biotechnology News. December 4, 2020. Retrieved June 11, 2025.
- ↑ Gertner, Jon (March 25, 2021). "Genome Sequencing and Covid‑19 – How Scientists Are Tracking the Virus". The New York Times Magazine. Retrieved June 11, 2025.
- ↑ Greenfieldboyce, Nell (October 10, 2022). "Artificial intelligence could soon diagnose illness based on the sound of your voice". NPR. Retrieved June 11, 2025.
- ↑ Wetsman, Nicole (September 13, 2022). "The sound of your voice might diagnose diseases". The Verge. Retrieved June 11, 2025.
- ↑ "Volastra Therapeutics Secures $60M in Series A". Citybiz. March 7, 2023. Retrieved June 11, 2025.
- ↑ Yeates, Mel J. (December 12, 2016). "PrOCTOR prediction: 'Moneyball' approach may help predict new drug toxicity in humans". Drug Discovery News. Retrieved June 11, 2025.
- ↑ "AACR Virtual Annual Meeting II: Opening Plenary Captures the Breadth of Cutting‑edge Cancer Research". American Association for Cancer Research. June 22, 2020. Retrieved June 11, 2025.
- ↑ Molteni, Megan (April 4, 2019). "AI Could Scan IVF Embryos to Help Make Babies More Quickly". Wired. Retrieved June 11, 2025.
- ↑ Kim, Junbum; Rustam, Samir; Mosquera, Juan M.; Randell, Scott H.; Shaykhiev, Renat; Rendeiro, André F.; Elemento, Olivier (2022). "Unsupervised discovery of tissue architecture in multiplexed imaging". Nature Methods. 19 (12): 1653–1661. doi:10.1038/s41592-022-01657-2. PMC 11102857 Check
|pmc=value (help). PMID 36316562 Check|pmid=value (help). - ↑ Rendeiro, André F.; Ravichandran, Hiranmayi; Bram, Yotam; Chandar, Varun; Kim, Jason; Meydan, Cem; Park, Jun; Foox, Jenny; Hether, Tyler; Warren, Scott; Kim, Yoo‑Kyung; Reeves, Jason; Salvatore, Saul; Mason, Christopher E.; Swanson, Elizabeth C.; Borczuk, Alain C.; Elemento, Olivier; Schwartz, Robert E. (2021). "The spatial landscape of lung pathology during COVID‑19 progression". Nature. 593 (7859): 564–569. Bibcode:2021Natur.593..564R. doi:10.1038/s41586-021-03475-6. PMC 8204801 Check
|pmc=value (help). PMID 33780969 Check|pmid=value (help). - ↑ "Scientific Review Council". Pershing Square Philanthropies. Retrieved June 11, 2025.
- ↑ "Leadership". Advancium Health Network. Retrieved June 11, 2025.
- ↑ "People". Owkin. Retrieved June 11, 2025.
- ↑ "Team". Harmonic Discovery. Retrieved June 11, 2025.
- ↑ "Team". Pannex Therapeutics. Retrieved June 11, 2025.
- ↑ Cavallo, Jo (February 10, 2018). "Making Personalized Medicine a Reality for More Patients With Cancer – A Conversation With Olivier Elemento, PhD". The ASCO Post. Retrieved June 11, 2025.
- ↑ Elemento, Olivier (February 25, 2018). "A New Regulatory Threat to Cancer Patients". The Wall Street Journal. Retrieved June 11, 2025.
- ↑ "Dr. Olivier Elemento awarded NSF CAREER grant". Weill Cornell Medicine. 2012. Retrieved June 11, 2025.
- ↑ "Olivier Elemento — VIVO profile". Weill Cornell Medicine. Retrieved June 11, 2025.
- ↑ "Dr. Olivier Elemento included in the Clarivate Highly Cited Researchers list". Clarivate. November 22, 2024. Retrieved June 11, 2025.
External links
- Official website
- Olivier Elemento publications indexed by Google Scholar
- Olivier Elemento on TwitterLua error in Module:WikidataCheck at line 23: attempt to index field 'wikibase' (a nil value).
This article "Olivier Elemento" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Olivier Elemento. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
